文献速递其他结缔组织病

超越极早期系统性硬化症:解读前硬皮病及其演变轨迹,为预防医学开辟新途径

Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine.
PubMed 文献 · Lancet Rheumatol · 2023-09-26

本文为个人观点文章,讨论在系统性硬化症极早期表现之前识别寡症状阶段(前硬皮病期)的概念框架,涉及高危人群识别、自身抗体及其潜在功能活性等参数与候选定义,并探讨该范式对系统性硬化症管理的潜在变革意义。

要点

  • 前硬皮病期指系统性硬化症极早期表现之前的寡症状阶段,此时尚无皮肤或器官的纤维化或不可逆表现。
  • 文章讨论了前硬皮病概念框架的候选定义参数,包括高危人群识别和自身抗体及其潜在功能活性。
  • 作者认为前硬皮病范式可能改变系统性硬化症管理方式,使高危器官受累或皮肤纤维化患者在此类事件发生前获得治疗。

核心结论

  • 作者认为前硬皮病这一新范式可能成为改变系统性硬化症管理方式的变革性方法,使高器官受累或皮肤纤维化风险的患者在此类事件发生前接受治疗。

研究设计与样本

  • 本文为个人观点文章,讨论前硬皮病概念框架的参数与候选定义,未报告系统检索方法或样本量。

主要发现

  • 作者提出前硬皮病期可在临床场景中被识别,此时疾病仍远未出现系统性硬化症相关的皮肤或器官纤维化或不可逆表现。
  • 文章从高危人群识别到自身抗体及其潜在功能活性等方面讨论了前硬皮病的候选定义参数。

局限性

  • 本文为个人观点文章,原文未报告系统检索方法或样本量,相关候选定义与参数尚待进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The identification of individuals with systemic sclerosis in an oligosymptomatic phase preceding the very early manifestations of the disease represents a challenge in the search for a new window of opportunity in systemic sclerosis. This phase could be identified in a clinical scenario as the pre-scleroderma phase, in which the disease would still be far from systemic sclerosis-related fibrotic or irreversible manifestations in skin or organs. In this Personal View, we discuss parameters and candidate definitions for a conceptual framework of pre-scleroderma, from the identification of populations at risk to autoantibodies and their potential functional activities. We discuss how this new paradigm of pre-scleroderma could represent a game-changing approach in the management of systemic sclerosis, allowing the treatment of patients at high risk of organ involvement or skin fibrosis before such events occur.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Lescoat A, Bellando-Randone S, Campochiaro C, et al. Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine. Lancet Rheumatol. 2023. PMID: 38251534. doi:10.1016/S2665-9913(23)00212-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。